Cellectis S.A. (CLLS) Executive Compensation
Cellectis S.A. (CLLS) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CLLS
CIK: 1627281
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: I0
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG SA
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerCédric Adens
Audit LocationParis La Défense, France
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-09-14 | 2026-09-14 | FORM 6-K | 0001171843-26-006010 | View SEC Doc Filr Page |
| 6-K | 2026-09-11 | 2026-09-11 | FORM 6-K | 0001171843-26-006002 | View SEC Doc Filr Page |
| 6-K/A | 2026-09-11 | 2026-06-30 | 6-K/A | 0001193125-26-389336 | View SEC Doc Filr Page |
| 6-K | 2026-09-01 | 2026-09-01 | FORM 6-K | 0001171843-26-005837 | View SEC Doc Filr Page |
| S-8 | 2026-08-06 | — | S-8 | 0001193125-26-338394 | View SEC Doc Filr Page |
| 6-K | 2026-08-06 | 2026-08-06 | FORM 6-K | 0001171843-26-005324 | View SEC Doc Filr Page |
| 6-K | 2026-08-06 | 2026-08-06 | 6-K | 0001193125-26-338220 | View SEC Doc Filr Page |
| 6-K | 2026-07-30 | 2026-07-30 | FORM 6-K | 0001171843-26-005091 | View SEC Doc Filr Page |
| 6-K/A | 2026-06-26 | 2026-06-26 | 6-K/A | 0001193125-26-285565 | View SEC Doc Filr Page |
| 6-K | 2026-06-25 | 2026-06-25 | FORM 6-K | 0001171843-26-004304 | View SEC Doc Filr Page |
| 6-K | 2026-06-25 | 2026-06-25 | 6-K | 0001193125-26-282865 | View SEC Doc Filr Page |
| 6-K | 2026-06-11 | 2026-06-11 | FORM 6-K | 0001171843-26-004051 | View SEC Doc Filr Page |
| 6-K | 2026-06-09 | 2026-06-09 | FORM 6-K | 0001171843-26-004006 | View SEC Doc Filr Page |
| 6-K | 2026-05-21 | 2026-05-20 | 6-K | 0001193125-26-232972 | View SEC Doc Filr Page |
| 6-K | 2026-05-20 | 2026-05-20 | FORM 6-K | 0001171843-26-003579 | View SEC Doc Filr Page |
| 6-K | 2026-05-12 | 2026-05-12 | FORM 6-K | 0001171843-26-003280 | View SEC Doc Filr Page |
| 6-K | 2026-05-11 | 2026-05-11 | FORM 6-K | 0001171843-26-003248 | View SEC Doc Filr Page |
| 6-K | 2026-05-11 | 2026-05-11 | 6-K | 0001193125-26-216901 | View SEC Doc Filr Page |
| 6-K | 2026-05-04 | 2026-05-04 | FORM 6-K | 0001171843-26-002982 | View SEC Doc Filr Page |
| 6-K | 2026-04-27 | 2026-04-27 | FORM 6-K | 0001171843-26-002734 | View SEC Doc Filr Page |
| 6-K | 2026-04-13 | 2026-04-13 | FORM 6-K | 0001171843-26-002410 | View SEC Doc Filr Page |
| 20-F | 2026-03-20 | 2025-12-31 | 20-F | 0001193125-26-116428 | View SEC Doc Filr Page |
| 6-K | 2026-03-20 | 2026-03-19 | FORM 6-K | 0001171843-26-001805 | View SEC Doc Filr Page |
| 6-K | 2026-03-12 | 2026-03-12 | FORM 6-K | 0001171843-26-001528 | View SEC Doc Filr Page |
| 6-K | 2026-01-08 | 2026-01-08 | FORM 6-K | 0001171843-26-000147 | View SEC Doc Filr Page |